Every story in this section, newest first — page 182 of 373.
Relay Therapeutics (NASDAQ:RLAY) announced positive initial data from an ongoing mid-stage clinical trial evaluating its precision medicine candidate, zovegalisib, in patients with rare genetic vascular anomalies.
Bilibili (NASDAQ:BILI) reported first-quarter financial results that met revenue expectations and turned a net profit, powered by robust advertising growth and heightened user engagement that cushioned its cooling mobile games division.
KE Holdings (NYSE:BEKE), China’s largest housing transactions platform, reported a 46.7% increase in first-quarter net income as internal cost optimization mitigated an extended contraction in the nation's new-home market.
Amer Sports (NYSE:AS) reported a 32% surge in first-quarter revenue, comfortably outpacing expectations as consumer demand accelerated for its premium technical outerwear and winter-sports gear.
LuxExperience (NYSE:LUXE) reported flat top-line performance on a constant-currency basis for the third quarter of fiscal year 2026, navigating geopolitical headwinds to secure its second consecutive quarter of profitability at the group level.
Baozun NASDAQ:BZUN), a leading brand e-commerce solution provider and digital commerce enabler in China, reported its unaudited financial results for the first quarter ended March 31, 2026.
The Home Depot (NYSE:HD) reported a 4.8% increase in net sales for the first quarter of fiscal 2026, navigating persistent housing market pressures and consumer uncertainty through expansion initiatives.
Agnico Eagle Mines (NYSE:AEM) has approved a positive investment decision for its Hope Bay gold project in Nunavut, advancing a multi-billion-dollar development in Canada’s far north as bullion prices hover near historic highs.
Michigan-linked medical technology sectors marked a significant consolidation as Stryker (NYSE:SYK) signed a definitive agreement to acquire Amplitude Vascular Systems (AVS) in a transaction valued at up to $835 million.
Hesai Group returned to net profitability during the first quarter of 2026, supported by an accelerating volume of sensor installations across the global electric vehicle and autonomous driving sectors.
Blackstone (NYSE:BX) and Alphabet Google (NYSE:GOOGL) have agreed to establish a new independent, U.S.-based technology company designed to expand enterprise access to artificial intelligence infrastructure and specialized semiconductor capacity.
CMB.TECH (NYSE:CMBT) reported a substantial increase in first-quarter profitability and revenue, boosted by elevated spot rates across major commercial shipping routes and significant capital gains from its asset disposal strategy.
ATRenew (NYSE:RERE) reported a significant acceleration in profitability for the first quarter of 2026, driven by robust top-line momentum and expanded margins across its pre-owned consumer electronics transaction platforms.
Bally’s Corp. (NYSE:BALY) reported a 28.3% surge in first-quarter revenue, hitting $755.7 million for the period ended March 31, 2026.
Agilysys (NASDAQ:AGYS) reported its financial results for the fiscal 2026 fourth quarter ended March 31, 2026, securing its 17th consecutive quarter of record-breaking top-line results.
CBAK Energy Technology (NASDAQ:CBAT) reported its unaudited financial results for the first quarter ended March 31, 2026, delivering an explosive near-doubling of its top-line revenue.
Ryanair Holdings plc (NASDAQ:RYAAY) reported its finalized, record-breaking financial results for the fiscal year ended March 31, 2026 (FY26), highlighting explosive bottom-line performance, strategic fuel defenses, and significant corporate restructuring.
Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) announced positive chemistry, manufacturing, and controls (CMC) data supporting the late-stage development of its lead antimicrobial candidate, Nu-3.
C3is (NASDAQ:CISS) announced its financial and operational results for the first quarter ended March 31, 2026, delivering substantial bottom-line expansion and enhanced operating leverage.
INNEOVA Holdings (NASDAQ:INEO) announced its audited financial results for the fiscal year ended December 31, 2025, charting a period of transition and operational realignment.
Design Therapeutics (NASDAQ:DSGN) announced positive biomarker and clinical findings from its ongoing Phase 1/2 RESTORE-FA clinical trial evaluating DT-216P2 in individuals with Friedreich ataxia (FA).
Brady Corporation (NYSE:BRC) reported its financial results for the fiscal 2026 third quarter ended April 30, 2026, delivering substantial top-line acceleration and record-setting profitability metrics.
AstraZeneca (NASDAQ:AZN) announced that the U.S. Food and Drug Administration (FDA) has approved BAXFENDY™ (baxdrostat) for the treatment of hypertension in adults.
WeTouch Technology (NASDAQ:WETH) reported its unaudited financial results for the first quarter ended March 31, 2026, delivering significant bottom-line acceleration and stable revenue growth.
